Univariable analysis | Multivariable analysis | |||||||
---|---|---|---|---|---|---|---|---|
p value | HR | 95% CI | p value | HR | 95% CI | |||
Lower | Upper | Lower | Upper | |||||
Initial PSA level | 0.820 | 1.020 | 0.863 | 1.204 | 0.157 | 0.862 | 0.701 | 1.059 |
Initial stage (M0 vs M1) | 0.091 | 0.776 | 0.578 | 1.042 | 0.469 | 0.876 | 0.611 | 1.254 |
Gleason score (8–10 vs 6–7) | 0.848 | 1.034 | 0.737 | 1.450 | 0.550 | 0.897 | 0.629 | 1.280 |
Time to CRPC | < 0.001 | 0.434 | 0.304 | 0.621 | 0.001 | 0.521 | 0.349 | 0.776 |
Chemotherapy (yes vs no) | < 0.001 | 2.300 | 1.731 | 3.057 | 0.001 | 1.683 | 1.232 | 2.300 |
Age at baseline (years) | 0.600 | 0.995 | 0.975 | 1.015 | 0.250 | 1.012 | 0.992 | 1.032 |
PSA level at baseline | < 0.001 | 1.958 | 1.680 | 2.282 | < 0.001 | 1.439 | 1.179 | 1.755 |
ALP level at baseline | < 0.001 | 5.138 | 3.509 | 7.524 | 0.019 | 1.827 | 1.102 | 3.028 |
LDH level at baseline | < 0.001 | 45.886 | 23.15 | 90.953 | < 0.001 | 12.123 | 5.343 | 27.51 |